Bayanin Kasuwar Nazari kan Hemoglobin ta Afirka da Rahoton Ci Gaba Mai Zurfi

Ɗan Afirka na'urar nazarin haemoglobin Kasuwa tana fuskantar wani matakin faɗaɗa tsarin da ke haifar da manyan cututtuka, rarraba kayayyakin kiwon lafiya, da kuma tallafin ƙasa da ƙasa tare da siyan jama'a. A matsayin kayan aiki na asali don gano cutar anemia, kula da cutar malaria da cututtukan jini, kula da lafiyar uwa da yara, da kuma amincin ƙarin jini, gwajin haemoglobin yana nuna babban shigar asibiti da kuma buƙatar da ake buƙata a duk matakan tsarin kiwon lafiya na Afirka.

1. Girman Kasuwa da Yanayin Ci Gaban Gabaɗaya

Ana sa ran kasuwar nazarin haemoglobin ta duniya za ta kai kimanin dala biliyan 2.0 zuwa biliyan 2.1 tsakanin 2025 da 2026, kuma ana sa ran za ta kai dala biliyan 3.1 zuwa biliyan 3.9 nan da 2033-2035, wanda hakan zai ci gaba da samun karuwar ci gaba a kowace shekara (CAGR) daga kashi 6.0 zuwa 7.1%. A yankin Gabas ta Tsakiya da Afirka (MEA), an kiyasta kasuwar nazarin haemoglobin a kusan dala miliyan 56 a shekarar 2024 kuma ana sa ran za ta karu zuwa dala miliyan 104 nan da shekarar 2033 a CAGR na kashi 7.2%, wanda hakan zai nuna tasirin kamawa sama da matsakaicin duniya. Gabaɗaya, Gabas ta Tsakiya da Afirka suna da kusan kashi 5.9% na kason kasuwar nazarin haemoglobin ta duniya.

Kasuwar na'urar nazarin haemoglobin ta Afirka tana nuna tsarin ci gaba mai matakai biyu masu sassa biyu. A asibitoci na tsakiya na birane da cibiyoyin kula da yankuna, na'urorin nazarin atomatik masu inganci da na'urorin nazarin benci sun mamaye; a duk duniya, na'urorin nazarin benci suna riƙe da kusan kashi 55% na kason kudaden shiga na kasuwa, yayin da na'urori masu sarrafa kansu ke wakiltar kusan kashi 60% na hannun jarin aiki, tsarin da ya dace da cibiyoyin kiwon lafiya na tsakiya a Afirka. Akasin haka, a asibitoci na karkara, cibiyoyin kiwon lafiya na al'umma (kamar IVs na Cibiyar Lafiya ta Uganda), da na'urorin tantancewa ta hannu, na'urorin auna haemoglobin masu hannu da na'urar aunawa (POCT) suna mamaye saitunan asibiti na farko saboda 'yancinsu daga yanayin dakin gwaje-gwaje masu rikitarwa, ayyukan reagent busasshe, ƙarfin baturi, da kuma sakamakon da aka samu cikin sauri cikin daƙiƙa.

2. Manyan Masu Haɗawa da Tarihin Cututtuka

Bukatar masu nazarin haemoglobin a Afirka ta samo asali ne daga yanayin annoba da kuma ƙalubalen lafiyar jama'a na yankin. Yawan cutar rashin jini, babban nauyin da ke tattare da cututtukan haemoglobinopathies da aka gada, da kuma ƙaruwar cututtukan da ke haifar da rayuwa, sun haɗa kai wajen samar da abubuwa uku da ke haifar da buƙatar asibiti.

A duk duniya, sama da mutane biliyan 1.6 zuwa 2.0 ne ke fama da cutar rashin jini, inda yankin kudu da hamadar Sahara ya fi samun yawan kamuwa da cutar a duk duniya, musamman tsakanin yara 'yan ƙasa da shekara 5, mata masu juna biyu, da mata masu shekaru haihuwa. A wannan yanki, karancin sinadarin ƙarfe mai gina jiki, cutar rashin jini da zazzabin cizon sauro ke haifarwa, da kuma cutar rashin jini da ke da alaƙa da cutar kanjamau/AIDS suna haifar da wani babban nauyi na haɗin gwiwa. A aikin asibiti, auna yawan haemoglobin cikin sauri da daidaito yana aiki a matsayin ma'aunin yanke shawara mai mahimmanci don tantance buƙatar yin ƙarin jini da kuma kimanta haɗarin yin ƙarin jini (kamar yadda aka nuna a gwajin asibiti na TRACT).

Ciwon haemoglobinopathies da aka gada yana da matuƙar illa ga lafiya a Afirka. A duk duniya, ana haihuwar jarirai kusan 330,000 kowace shekara tare da mummunan rashin daidaituwar haemoglobin. Daga cikin waɗannan, cutar sikila (SCD) tana shafar kusan mutane miliyan 7.74 a duk duniya, tare da kusan sabbin jarirai 515,000 da ke kamuwa da cutar a kowace shekara - har zuwa kashi 80% na waɗanda ke faruwa a yankin kudu da hamadar Sahara. Saboda rashin kulawa da cutar sikila yana haifar da mace-mace mai yawa a ƙasa da shekaru 5, UNICEF, WHO, da ma'aikatun lafiya na gida suna ƙarfafa shirye-shiryen tantance jarirai da uwaye, wanda ke haifar da siyan gwaje-gwajen da aka keɓe don nau'in haemoglobin da jimlar haemoglobin.

Bugu da ƙari, ƙaruwar cututtukan da ke haifar da rashin lafiya na rayuwa na haifar da sabbin buƙatun ganewar asali. A cewar Ƙungiyar Ciwon Suga ta Duniya (IDF), ana hasashen cewa adadin mutanen da ke fama da ciwon suga a Afirka zai ƙaru daga miliyan 24 a shekarar 2021 zuwa miliyan 55 nan da shekarar 2045 - ƙaruwa da kashi 134%, wanda ya fi kowanne girma a tsakanin dukkan yankunan duniya. A halin yanzu, adadin waɗanda suka kamu da ciwon suga da ba a gano ba a Gabas ta Tsakiya da Afirka ya kai kashi 44.7%. Wannan yanayin yana ƙara yawan buƙatar na'urori masu iya yin gwajin haemoglobin da glycated hemoglobin (HbA1c), wanda ke hanzarta shigar da na'urorin nazarin HbA1c na POCT cikin asibitoci na birane na Afirka da cibiyoyin kula da marasa lafiya na musamman.

3. Kwatanta Fasaha da Binciken Tsarin Samfura

Akwai manyan hanyoyi guda uku na fasaha a kasuwar Afirka a halin yanzu, kowannensu ya dace da matakan kiwon lafiya daban-daban, yanayin tattalin arziki, da kuma yanayin aiki:

Photometry na Microfluidic Microcuvette

Na'urar daukar hoton microcuvette, wacce HemoCue (misali, Hb 301, Hb 201), EKF Diagnostics (Hemo Control, DiaSpect Tm), Infopia na Koriya (VERI-Q Red), da ACON (ACON Mission Hb), ke aiki a matsayin ma'aunin zinare a cikin POCT na Afirka. Wannan fasaha tana amfani da ƙananan ƙwayoyin cuta don zana jinin ƙananan ƙwayoyin cuta (yawanci 10-15 μL), tana amsawa da busassun ƙwayoyin cuta a ciki ko amfani da takamaiman raƙuman haske don auna spectrophotometric don samar da sakamako cikin daƙiƙa. A cikin kimantawa na asibiti da yawa a ƙasashe kamar Uganda, na'urori kamar HemoCue Hb 301, DiaSpect Tm, da Hemo Control sun nuna alaƙa mai ƙarfi (r ≥ 0.9) akan ma'aunin Beckman Coulter na dakin gwaje-gwaje, tare da nuna son kai a cikin ± 1 g/dL. Waɗannan na'urori sun shawo kan matsalolin hanyoyin sinadarai na gargajiya (kamar hanyar Sahli) waɗanda suka dogara da shirye-shiryen reagent da hannu da kuma yanayin dakin gwaje-gwaje, wanda hakan ya sa suka zama babbar fasahar da aka yi amfani da ita a matakin kulawa ta farko.

Masu Nazarin Hematology ta atomatik (Gwajin CBC da aka Haɗa)

A asibitoci na sakandare da na manyan makarantu, yawanci ana haɗa tantancewar haemoglobin cikin na'urorin nazarin jini na Complete Blood Count (CBC). Waɗannan tsarin suna amfani da fasahar hana wutar lantarki, cytometry na kwararar laser, da fasahar fenti mai haske (kamar fasahar Mindray's 3D SF Cube) don ƙididdige bambancin ƙwayoyin jini, tare da auna launi don haemoglobin. Tare da iyakancewar kasafin kuɗi da ƙarancin ƙwararrun ma'aikata na fasaha, ƙananan dakunan gwaje-gwaje a Afirka suna da babban adadin sayayya ga masu nazarin bambanci na sassa 3 (kamar Mindray BC-20s, BC-30s). Waɗannan kayan aikin suna ba da sigogi 19 zuwa 21 tare da ƙarancin farashin kowane gwaji da sauƙi kulawa. A manyan asibitoci na manyan makarantu, ana amfani da na'urori masu nazarin bambanci na sassa 5 (kamar jerin Mindray BC-5000/6000 da jerin Sysmex XN) don cikakken binciken cututtukan jini.

Sensing na Hemoglobin na gani mara zagi

Fasahar CO-oximetry mai hana zamba wacce Masimo (Pronto, Pronto-7, Rad-57) ta wakilta, tana amfani da na'urori masu auna zafin jiki masu yawa (fasahar Rainbow SET) don auna jimlar haemoglobin (SpHb) ta hanyar transcutaneous. Fasaha mara hana zamba tana ba da fa'idodi na ka'ida kamar ciwon allura babu komai, haɗarin kamuwa da cuta babu komai, da kuma farashin tsiri mara komai. Duk da haka, nazarin asibiti ya nuna cewa na'urori marasa amfani suna fuskantar ƙalubale game da daidaito da hankali a yanayin asibiti na Afirka; Masimo Pronto ya nuna ma'aunin tantance R kawai.² = 0.29 akan hanyoyin binciken dakin gwaje-gwaje, ƙasa da HemoCue Hb-301 (R) sosai² = 0.87) da Hb-801 (R)² = 0.88). Bugu da ƙari, Masimo Pronto ya nuna rashin jin daɗi na kashi 45.7% kawai don gano cutar anemia kuma ya kasa gano cutar anemia mai tsanani ƙasa da 4 g/dL, wanda hakan ya takaita amfaninta a cikin kulawar gaggawa da kuma gwajin cutar anemia mai tsanani.

4. Tsarin Zane-zanen Yanayi da Sayayya Mai Kyau

Yanayin gasa na kasuwar nazarin haemoglobin ta Afirka yana nuna rarrabuwar kawuna tsakanin manyan samfuran Turai/Amurka da masana'antun Asiya.

Masana'antun Turai da Amurka waɗanda Danaher's HemoCue, Abbott, Sysmex, Roche Diagnostics, da Siemens Healthineers suka wakilta sun mamaye matsayi mai kyau. Daga cikinsu, HemoCue tana da rinjayen amincin alama a gwajin haemoglobin na POCT; tsarin Hb 201 da Hb 301 sun mamaye ayyukan da masu ba da gudummawa ke tallafawa da kuma siyan cibiyoyin jinin jama'a. Abbott yana amfani da jerin masu nazarin CELL-DYN da dandamalin Pima mai ɗaukuwa tare da haɗin gwiwar ƙungiyoyi masu zaman kansu (NGOs) don gudanar da asibitoci masu motsi, suna zurfafa shiga cikin gwajin lafiyar uwa da yara.

A lokaci guda, masana'antun Asiya kamar Mindray, Sinocare, ACON Laboratories, Rayto, da Konsung suna samun kasuwa cikin sauri. Mindray ya kafa wani muhimmin matsayi a kasuwar nazarin jinin mutum-mutumi ta atomatik a Afirka saboda babban ingancin kayan aiki da ƙarancin kuɗin kulawa. Na'urorin nazarinsa masu sassa 3 (misali, BC-20s, BC-30s) sun zama manyan zaɓuɓɓuka ga ƙananan asibitoci na Afirka da dakunan gwaje-gwaje masu zaman kansu saboda ƙarancin sawun su da ƙarancin amfani da reagent. Mindray kuma yana faɗaɗa sawun alamar ta hanyar haɗin gwiwa da ƙungiyoyi kamar Mercy Ships (jirgin ruwan asibiti) da Netcare na Afirka ta Kudu. A fannin POCT, Sinocare da ACON Laboratories suna lalata ikon mallakar Turai a cikin tsarin microcuvette ta hanyar kayan aiki da tsiri masu rahusa, suna ɗaukar hannun jarin kasuwa a asibitoci masu zaman kansu da shagunan sayar da kayayyaki.

Tashoshin sayayya sun kasu kashi biyu na manyan rukuni:

• Taimakon Ƙasashen Duniya da Sayen Kayayyaki Masu Yawa: Ƙungiyoyi kamar UNICEF, WHO, Asusun Duniya, da PEPFAR suna siyan na'urorin auna haemoglobin a tsakiyar ƙasashen Afirka ta hanyar tayin haɗin gwiwa. Waɗannan sayayya suna da matuƙar muhimmanci ga maimaita gwaji, juriyar jiki a cikin yanayi mai zafi da danshi, da kuma kimantawa/haɗawa cikin Jerin Samfurin WHO na Mahimmancin Binciken In Vitro (EDL).
• Sayen Kasuwanci na Jama'a da Masu Zaman Kansu na Gida: Saboda takaitaccen tanadin kuɗin ƙasashen waje da ƙarancin kasafin kuɗi, asibitoci na gwamnati da asibitoci masu zaman kansu sun fi mai da hankali kan Jimlar Kuɗin Mallaka (TCO), buɗe damammaki ga masana'antun da ke ba da damar sabis na gida da fa'idodin farashi.

5. Bambancin Kasuwa na Yankuna da Shingayen Tsarin

Kasuwar na'urorin likitanci ta Afirka ba ta da alaƙa da juna; akwai manyan bambance-bambance a yankuna dangane da ci gaban tattalin arziki, kashe kuɗin kiwon lafiya, da kuma tsarin dokoki:

Muhimman Halayen Kasuwar Yanki

• Afirka ta Kudu: Yana da tsarin kula da lafiya na gwamnati da masu zaman kansu mafi ci gaba a nahiyar. Hukumar Kula da Kayayyakin Lafiya ta Afirka ta Kudu (SAHPRA) ta cimma matakin girma na WHO (ML3), inda ta kafa tsarin dokoki masu girma. Ƙasar ta nuna buƙatar masu nazari masu sassa 5 masu inganci da kuma na'urorin POCT masu inganci.
• Najeriya da Yammacin Afirka: A matsayinta na ƙasa mafi yawan jama'a a Afirka, Najeriya tana ɗauke da babban nauyin cutar anemia da cutar sikila. Kasuwar tana ƙarƙashin kashe kuɗi daga aljihunta da asibitoci masu zaman kansu, wanda hakan ke sa sayayya ta zama mai matuƙar muhimmanci ga farashi. Hukumar Kula da Abinci da Magunguna ta Ƙasa (NAFDAC) ta tilasta tsauraran ƙa'idojin rajistar shigo da kayan aikin likita da kuma share kwastam.
• Gabashin Afirka (Kenya, Uganda, Tanzania): Hukumar Magunguna da Guba ta Kenya, Hukumar Kula da Magunguna da Na'urorin Lafiya ta Tanzania (TMDA), da Hukumar Kula da Magunguna ta Ƙasa (NDA) ta Uganda ne suka tsara tsarin dokoki a Gabashin Afirka. Gabashin Afirka yana ɗaya daga cikin yankunan da suka fi aiki don tura POCT, wanda ayyukan ƙasa da ƙasa na ƙungiyoyin NGO ke jagoranta sosai.
• Misira da Arewacin AfirkaKasashen Arewacin Afirka suna da ingantattun kayayyakin more rayuwa na kiwon lafiya da kuma kasafin kuɗi mafi girma na kiwon lafiya; yawan buƙatar na'urorin nazarin na'urori masu sarrafa kansu na benchtop ya fi girma fiye da na ƙasashen kudu da hamadar Sahara.

Matsalolin Tsarin Gida da Shisshigin Kasuwa

Duk da tsananin buƙata, yin aiki a kasuwar nazarin haemoglobin ta Afirka ya ƙunshi shawo kan matsaloli da yawa na tsarin.

Na farko shine "Tarkon Kudin Microcuvette"Duk da cewa kayan aikin POCT masu inganci suna da matsakaicin farashi (~$250–$350 USD), farashin microcuvette na kowane gwaji zai iya kaiwa ~$4.0 USD, idan aka kwatanta da hanyoyin sinadarai na gargajiya (~$0.25 USD). Saboda ƙarancin kasafin kuɗin lafiyar jama'a a yankin kudu da hamadar Sahara, tsadar kayan abinci da ake kashewa akai-akai yakan bar na'urorin da aka bayar ko aka saya ba tare da aiki ba da zarar an kammala zagayen tallafin ƙasa da ƙasa.

Na biyu shine Kalubalen Yanayin Kariya da Zafin Jiki a Tsarin Samar da KayayyakiYankin kudu da hamadar Sahara yana fuskantar jinkirin share kwastam na kayan aikin gano cututtuka da aka shigo da su daga ƙasashen waje tare da ƙarancin musayar kuɗi. Bugu da ƙari, matsanancin zafi da danshi na yanayi suna haifar da babban buƙata don adana kayan aikin ruwa da busassun ƙananan na'urori, inda rashin isasshen kayan aikin sarkar sanyi yakan haifar da lalacewar kayan aikin.

Na uku shine Raguwa a cikin Ayyukan Bayan Siyarwa da Ma'aikata Masu ƘwarewaLokacin rashin aiki a wuraren aiki matsala ce da ta zama ruwan dare a faɗin cibiyoyin Afirka. Karancin ƙwararrun ma'aikatan dakin gwaje-gwaje da injiniyoyin hidimar filin, tare da rashin kayan gyara na musamman, yana barin kayan aikin da ba su da inganci ba su yi aiki na tsawon lokaci.

Na huɗu shine Tsarin Bin Dokoki da DogaraTsarin rajista na ƙasa-da-ƙasa da aka raba zuwa ƙasashe yana ƙara farashin bin ƙa'ida. Duk da haka, hukumomi kamar SAHPRA suna aiwatar da hanyoyin dogaro da ƙa'idoji sosai - suna amfani da kimantawa da aka yi a baya daga hukumomin da aka amince da su (misali, EMA, US FDA, WHO Pre-Certification) don hanzarta amincewa da gida - suna ba da hanya mai sauri don samfuran da ke da takaddun shaida na ƙasashen duniya.

6. Kammalawa da Shawarwari Masu Mahimmanci

Kasuwar nazarin haemoglobin ta Afirka tana canzawa daga "ƙarfafa POCT ta hanyar taimako" zuwa tsarin hanya biyu inda "POCT da bincike mai inganci da inganci, na gida mai sarrafa kansa suna rayuwa tare". Ga masana'antun da ke neman zurfafa kasancewarsu a wannan yanki, gasa ta gaba za ta dogara ne akan dorewar kayan aiki, juriyar sarkar samar da kayayyaki, da kuma iyawar sabis na gida.

Kamfanoni ya kamata su gina tsarin kasuwanci mai rufewa na "kayan aiki masu dorewa + kayan amfani masu araha," suna haɓaka busassun ƙananan ƙwayoyin cuta ko tsarin tsiri mai ƙarancin girma tare da farashin reagent mai sarrafawa don daidaita ƙarfin siyan kiwon lafiya na farko a Afirka, ta haka ne za su shawo kan shingen farashin amfani. A fannin samar da kayayyaki da sabis, masana'antun dole ne su wuce tallace-tallace masu sauƙi na fitarwa ta hanyar kafa wuraren adana kayan aiki na yanki da cibiyoyin horar da fasaha a manyan ƙasashe kamar Afirka ta Kudu, Najeriya, da Kenya don inganta lokutan amsawa bayan siyarwa. Bugu da ƙari, daidaitawa da haɗin gwiwar yanki na Afirka da daidaiton dokoki, tabbatar da rajista ta farko a ƙasashen da ke da sa ido kan ƙa'idoji masu girma (kamar SAHPRA ML3) da amfani da hanyoyin dogaro da ƙa'idoji na iya rage lokacin shiga kasuwa a cikin ƙasashe maƙwabta. A ƙarshe, idan aka yi la'akari da ƙaruwar ciwon suga da rashin jini a faɗin Afirka, dandamalin bincike mai ɗaukan kaya guda ɗaya waɗanda suka haɗa jimlar haemoglobin da gwajin glycated hemoglobin (HbA1c) za su fito a matsayin babban abin da ke haifar da ci gaba ga sayayya na gwamnati da na masu zaman kansu.